Publicacions en què col·labora amb Jara Llenas García (11)

2015

  1. Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5

  2. Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5

2014

  1. Incidence of Hepatitis C Virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: Increasing rates of HCV diagnosis but not of HCV seroconversions

    PLoS ONE, Vol. 9, Núm. 12

  2. Tuberculosis in a cohort of HIV-positive patients: Epidemiology, clinical practice and treatment outcomes

    International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 6

2013

  1. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?

    AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 25, Núm. 8, pp. 980-989

  2. Should we look for Strongyloides stercoralis in foreign-born HIV-infected persons?

    Journal of Immigrant and Minority Health, Vol. 15, Núm. 4, pp. 796-802

2012

  1. Características clínico-epidemiológicas de los pacientes inmigrantes con infección por el VIH: estudio de 371 casos

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 8, pp. 441-451

  2. Chagas disease screening among HIV-positive Latin American immigrants: An emerging problem

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 8, pp. 1991-1997

2011

  1. Sustained profile of transmitted drug resistance mutations for more than 10 years in an HIV type 1-infected patient

    AIDS Research and Human Retroviruses, Vol. 27, Núm. 1, pp. 41-45

2010

  1. Serum (1→3) β-D-glucan as a noninvasive adjunct marker for the diagnosis and follow-up of pneumocystis jiroveci Pneumonia in patients with HIV infection

    Clinical Infectious Diseases

2008

  1. Lopinavir/ritonavir monotherapy as a simplification strategy in the treatment of HIV-1 infection

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 16, pp. 12-20